Next Article in Journal
Correction: Omole et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. Vaccines 2025, 13, 192
Previous Article in Journal
Self-Reporting of Post-Vaccination Symptoms in the COVID-19 Vaccination Process for Teachers in a North Region of Poland
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Article

Article Versions Notes

Vaccines 2025, 13(10), 1055; https://doi.org/10.3390/vaccines13101055
Action Date Notes Link
article html file updated 16 October 2025 04:56 CEST Update https://www.mdpi.com/2076-393X/13/10/1055/html
article pdf uploaded. 16 October 2025 04:53 CEST Updated version of record https://www.mdpi.com/2076-393X/13/10/1055/pdf
article xml uploaded. 16 October 2025 04:53 CEST Update https://www.mdpi.com/2076-393X/13/10/1055/xml
article xml file uploaded 16 October 2025 04:53 CEST Update -
article html file updated 16 October 2025 04:27 CEST Update -
article pdf uploaded. 16 October 2025 04:26 CEST Updated version of record https://www.mdpi.com/2076-393X/13/10/1055/pdf-vor
article xml uploaded. 16 October 2025 04:26 CEST Update -
article xml file uploaded 16 October 2025 04:26 CEST Update -
article html file updated 15 October 2025 10:44 CEST Original file -
article supplementary file uploaded. 15 October 2025 10:41 CEST - https://www.mdpi.com/2076-393X/13/10/1055#supplementary
article pdf uploaded. 15 October 2025 10:41 CEST Version of Record https://www.mdpi.com/2076-393X/13/10/1055/pdf-vor
article xml uploaded. 15 October 2025 10:41 CEST Update -
article xml file uploaded 15 October 2025 10:41 CEST Original file -
Back to TopTop